Epidemiological features of invasive and noninvasive group A streptococcal disease in the Netherlands, 1992–1996

  • B. Vlaminckx
  • W. van Pelt
  • L. Schouls
  • A. van Silfhout
  • C. Elzenaar
  • E. Mascini
  • J. Verhoef
  • J. Schellekens
Article

Abstract

A prospective, nationwide, laboratory-based surveillance of invasive group A streptococcal infections was conducted in the Netherlands from 1992 through 1996. Clinical and demographic data were obtained and all isolates were T/M typed. All noninvasive group A streptococcal isolates were registered from 1994 through 1996. A total of 880 patients with invasive streptococcal disease were identified. The annual incidence was found to be 2.2 per 100,000. Predominant M types were M1 (21%), M3 (11%), M6 (5%), M12 (5%), and M28 (8%). Particular age and M-type distributions were observed in different clinical entities. The case-fatality rate was 18% overall, but it reached 59% among cases of toxic shock-like syndrome. Older age, necrotizing fasciitis, sepsis without focus, pneumonia, infection with type M1 or M3 strains, and underlying cardiopulmonary disease were associated with fatality. A total of 10,105 patients with noninvasive group A streptococcal disease were registered. These patients differed significantly from patients with invasive disease with regard to age distribution and primary foci of infection.

References

  1. 1.
    Bisno AL (1990) Nonsuppurative poststreptococcal sequelae: rheumatic fever and glomerulonephritis. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice of infectious diseases. Churchill Livingstone, New York, pp 1799–1810Google Scholar
  2. 2.
    O’Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM, Danila R, Zell ER, Facklam R, Schwartz B, Schuchat A (2002) Epidemiology of invasive group A streptococcus disease in the United States, 1995–1999. Clin Infect Dis 35:268–276PubMedGoogle Scholar
  3. 3.
    Sharkawy A, Low DE, Saginur R, Gregson D, Schwartz B, Jessamine P, Green K, McGeer A (2002) Severe group A streptococcal soft-tissue infections in Ontario: 1992–1996. Clin Infect Dis 34:454–460CrossRefPubMedGoogle Scholar
  4. 4.
    Cone LA, Woodard DR, Schlievert PM, Tomory GS (1987) Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med 317:146–149PubMedGoogle Scholar
  5. 5.
    Gaworzewska E, Colman G (1988) Changes in the pattern of infection caused by Streptococcus pyogenes. Epidemiol Infect 100:257–269PubMedGoogle Scholar
  6. 6.
    Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546–1554CrossRefPubMedGoogle Scholar
  7. 7.
    Schwartz B, Facklam RR, Breiman RF (1990) Changing epidemiology of group A streptococcal infection in the USA. Lancet 336:1167–1171PubMedGoogle Scholar
  8. 8.
    Bisno AL (1991) Group A streptococcal infections and acute rheumatic fever. N Engl J Med 325:783–793PubMedGoogle Scholar
  9. 9.
    Colman G, Tanna A, Efstratiou A, Gaworzewska ET (1993) The serotypes of Streptococcus pyogenes present in Britain during 1980–1990 and their association with disease. J Med Microbiol 39:165–178PubMedGoogle Scholar
  10. 10.
    Ferrieri P (1991) Microbiological features of current virulent strains of group A streptococci. Pediatr Infect Dis J 10:S20–S24PubMedGoogle Scholar
  11. 11.
    Hauser AR, Stevens DL, Kaplan EL, Schlievert PM (1991) Molecular analysis of pyogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Microbiol 29:1562–1567PubMedGoogle Scholar
  12. 12.
    Johnson DR, Stevens DL, Kaplan EL (1992) Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 166:374–382PubMedGoogle Scholar
  13. 13.
    Musser JM, Hauser AR, Kim MH, Schlievert PM, Nelson K, Selander RK (1991) Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci USA 88:2668–2672PubMedGoogle Scholar
  14. 14.
    Reichardt W, Muller-Alouf H, Alouf JE, Kohler W (1992) Erythrogenic toxins A, B and C: occurrence of the genes and exotoxin formation from clinical Streptococcus pyogenes strains associated with streptococcal toxic shock-like syndrome. FEMS Microbiol Lett 79:313–322PubMedGoogle Scholar
  15. 15.
    Stromberg A, Romanus V, Burman LG (1991) Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. J Infect Dis 164:595–598PubMedGoogle Scholar
  16. 16.
    Johnson DR, Wotton JT, Shet A, Kaplan EL (2002) A comparison of group A streptococci from invasive and uncomplicated infections: are virulent clones responsible for serious streptococcal infections? J Infect Dis 185:1586–1595CrossRefPubMedGoogle Scholar
  17. 17.
    Mascini EM, Jansze M, Schellekens JF, Musser JM, Faber JA, Verhoef-Verhage LA, Schouls L, van Leeuwen WJ, Verhoef J, van Dijk H (2000) Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies. J Infect Dis 181:631–638Google Scholar
  18. 18.
    Schellekens JF, Schouls L, van Silfhout A, Elzenaar K, Brunings H, Blokpoel M, Top J, van Leeuwen WJ (1994) Invasieve infecties door beta-haemolytische Streptokokken Lancefield Groep A (Streptococcus pyogenes) in Nederland, 1992–1993. Report No. 253631001 of the National Institute of Public Health and Environmental Protection (RIVM). RIVM, BilthovenGoogle Scholar
  19. 19.
    Schellekens JF, Schouls LM, van Pelt W, Esveld M, van Leeuwen WJ (1998) Group A streptococci: a change in virulence? Neth J Med 52:209CrossRefPubMedGoogle Scholar
  20. 20.
    The Working Group on Severe Streptococcal Infections (1993) Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. J Am Med Assoc 269:390–391CrossRefGoogle Scholar
  21. 21.
    Griffith F (1934) The serologic classification of Streptococcus pyogenes. J Hyg Camb 34:542–584Google Scholar
  22. 22.
    Kaufhold A, Podbielski A, Baumgarten G, Blokpoel M, Top J, Schouls L (1994) Rapid typing of group A streptococci by the use of DNA amplification and non-radioactive allele-specific oligonucleotide probes. FEMS Microbiol Lett 119:19–25CrossRefPubMedGoogle Scholar
  23. 23.
    Hosmer DW, Lemeshow S (1989) Applied logistic regression. Wiley, New York, pp 82–134Google Scholar
  24. 24.
    Davies HD, McGeer A, Schwartz B, Green K, Cann D, Simor AE, Low DE (1996) Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 335:547–554PubMedGoogle Scholar
  25. 25.
    Centers for Disease Control and Prevention (2002) Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention. Clin Infect Dis 35:950–959CrossRefPubMedGoogle Scholar
  26. 26.
    Svensson N, Oberg S, Henriques B, Holm S, Kallenius G, Romanus V, Giesecke J (2000) Invasive group A streptococcal infections in Sweden in 1994 and 1995: epidemiology and clinical spectrum. Scand J Infect Dis 32:609–614CrossRefPubMedGoogle Scholar
  27. 27.
    Andersen MM, Ronne T (1995) Group A streptococcal bacteraemias in Denmark 1987–1989. J Infect 31:33–37CrossRefPubMedGoogle Scholar
  28. 28.
    Martin PR, Hoiby EA (1990) Streptococcal serogroup A epidemic in Norway 1987–1988. Scand J Infect Dis 22:421–429PubMedGoogle Scholar
  29. 29.
    Bibler MR, Rouan GW (1986) Cryptogenic group A streptococcal bacteremia: experience at an urban general hospital and review of the literature. Rev Infect Dis 8:941–951PubMedGoogle Scholar
  30. 30.
    Ispahani P, Donald FE, Aveline AJ (1988) Streptococcus pyogenes bacteraemia: an old enemy subdued, but not defeated. J Infect 16:37–46PubMedGoogle Scholar
  31. 31.
    Muller MP, Low DE, Green KA, Simor AE, Loeb M, Gregson D, McGeer A (2003) Clinical and epidemiologic features of group A streptococcal pneumonia in Ontario, Canada. Arch Intern Med 163:467–472CrossRefPubMedGoogle Scholar
  32. 32.
    Beall B, Facklam R, Hoenes T, Schwartz B (1997) Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995. J Clin Microbiol 35:1231–1235PubMedGoogle Scholar
  33. 33.
    Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ (1993) The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. J Am Med Assoc 269:384–389CrossRefGoogle Scholar
  34. 34.
    Kiska DL, Thiede B, Caracciolo J, Jordan M, Johnson D, Kaplan EL, Gruninger RP, Lohr JA, Gilligan PH, Denny FW Jr (1997) Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J Infect Dis 176:992–1000PubMedGoogle Scholar
  35. 35.
    Lehtonen OP, Kero P, Ruuskanen O, Gaworzewska ET, Hollo O, Erkkola R, Salmi T (1987) A nursery outbreak of group A streptococcal infection. J Infect 14:263–270PubMedGoogle Scholar
  36. 36.
    Centers for Disease Control and Prevention (2003) Outbreak of group A streptococcal pneumonia among Marine Corps recruits, California, November 1–December 20, 2002. MMWR Morb Mortal Wkly Rep 52:106–109PubMedGoogle Scholar
  37. 37.
    Muotiala A, Saxen H, Vuopio-Varkila J (1997) Group A streptococcal outbreak of perianal infection in a day-care centre. Adv Exp Med Biol 418:211–215PubMedGoogle Scholar
  38. 38.
    Petersen JP, Kaltoft MS, Misfeldt JC, Schumacher H, Schonheyder HC (2003) Community outbreak of perianal group A streptococcal infection in Denmark. Pediatr Infect Dis J 22:105–109CrossRefPubMedGoogle Scholar
  39. 39.
    Jaffe J, Natanson-Yaron S, Caparon MG, Hanski E (1996) Protein F2, a novel fibronectin-binding protein from Streptococcus pyogenes, possesses two binding domains. Mol Microbiol 21:373–384CrossRefPubMedGoogle Scholar
  40. 40.
    Natanson S, Sela S, Moses AE, Musser JM, Caparon MG, Hanski E (1995) Distribution of fibronectin-binding proteins among group A streptococci of different M types. J Infect Dis 171:871–878PubMedGoogle Scholar
  41. 41.
    Rocha CL, Fischetti VA (1999) Identification and characterization of a novel fibronectin-binding protein on the surface of group A streptococci. Infect Immun 67:2720–2728PubMedGoogle Scholar
  42. 42.
    Valentin-Weigand P, Talay SR, Kaufhold A, Timmis KN, Chhatwal GS (1994) The fibronectin binding domain of the Sfb protein adhesin of Streptococcus pyogenes occurs in many group A streptococci and does not cross-react with heart myosin. Microb Pathog 17:111–120CrossRefPubMedGoogle Scholar
  43. 43.
    Eriksson BK, Andersson J, Holm SE, Norgren M (1998) Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome. Clin Infect Dis 27:1428–1436PubMedGoogle Scholar
  44. 44.
    Lancefield RC (1959) Persistence of type-specific antibodies in man following infection with group A streptococci. J Exp Med 110:271–292PubMedGoogle Scholar
  45. 45.
    Basma H, Norrby-Teglund A, Guedez Y, McGeer A, Low DE, El Ahmedy O, Schwartz B, Kotb M (1999) Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect Immun 67:1871–1877PubMedGoogle Scholar
  46. 46.
    Norrby-Teglund A, Pauksens K, Holm SE, Norgren M (1994) Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease. J Infect Dis 170:585–591PubMedGoogle Scholar
  47. 47.
    Davidson M, Parkinson AJ, Bulkow LR, Fitzgerald MA, Peters HV, Parks DJ (1994) The epidemiology of invasive pneumococcal disease in Alaska, 1986–1990, ethnic differences and opportunities for prevention. J Infect Dis 170:368–376PubMedGoogle Scholar
  48. 48.
    Jones DM, Mallard RH (1993) Age incidence of meningococcal infection in England and Wales, 1984–1991. J Infect 27:83–88PubMedGoogle Scholar
  49. 49.
    Bucher A, Martin PR, Hoiby EA, Halstensen A, Odegaard A, Hellum KB, Westlie L, Hallan S (1992) Spectrum of disease in bacteraemic patients during a Streptococcus pyogenes serotype M-1 epidemic in Norway in 1988. Eur J Clin Microbiol Infect Dis 11:416–426PubMedGoogle Scholar
  50. 50.
    Ho PL, Johnson DR, Yue AW, Tsang DN, Que TL, Beall B, Kaplan EL (2003) Epidemiologic analysis of invasive and noninvasive group A streptococcal isolates in Hong Kong. J Clin Microbiol 41:937–942CrossRefPubMedGoogle Scholar
  51. 51.
    Zwart S, Ruijs GJ, Sachs AP, van Leeuwen WJ, Gubbels JW, de Melker RA (2000) Beta-haemolytic streptococci isolated from acute sore-throat patients: cause or coincidence? A case-control study in general practice. Scand J Infect Dis 32:377–384CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • B. Vlaminckx
    • 1
  • W. van Pelt
    • 2
  • L. Schouls
    • 2
  • A. van Silfhout
    • 2
  • C. Elzenaar
    • 2
  • E. Mascini
    • 1
  • J. Verhoef
    • 1
  • J. Schellekens
    • 2
  1. 1.Eijkman Winkler Institute for Medical Microbiology, Infectious Diseases and InflammationUniversity Medical Center UtrechtUtrechtThe Netherlands
  2. 2.National Institute of Public Health and the Environment (RIVM)BilthovenThe Netherlands

Personalised recommendations